Patents by Inventor T. Aaron Dyer

T. Aaron Dyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR SUSTAINED DELIVERY OF DRUGS
    Publication number: 20150174211
    Abstract: The present disclosure relates to methods and compositions for the topical sustained delivery of therapeutic agents. Topical application of compositions containing a muscle fasciculating agent result in the sustained release of any therapeutic agent contained within the composition. More particularly, topical application of such compositions to the outer surface of the eyelid of a patient results in increased absorption and sustained release of the therapeutic agent into the eyes or systemically.
    Type: Application
    Filed: March 9, 2015
    Publication date: June 25, 2015
    Inventors: Padma NANDURI, T. Aaron DYER
  • Methods and compositions for sustained delivery of drugs
    Patent number: 9034830
    Abstract: The present disclosure relates to methods and compositions for the topical sustained delivery of therapeutic agents. Topical application of compositions containing a muscle fasciculating agent result in the sustained release of any therapeutic agent contained within the composition. More particularly, topical application of such compositions to the outer surface of the eyelid of a patient results in increased absorption and sustained release of the therapeutic agent into the eyes or systemically.
    Type: Grant
    Filed: October 29, 2010
    Date of Patent: May 19, 2015
    Assignee: INTRATUS, INC.
    Inventors: Padma Nanduri, T. Aaron Dyer
  • METHODS AND COMPOSITIONS FOR SUSTAINED DELIVERY OF DRUGS
    Publication number: 20110104206
    Abstract: The present disclosure relates to methods and compositions for the topical sustained delivery of therapeutic agents. Topical application of compositions containing a muscle fasciculating agent result in the sustained release of any therapeutic agent contained within the composition. More particularly, topical application of such compositions to the outer surface of the eyelid of a patient results in increased absorption and sustained release of the therapeutic agent into the eyes or systemically.
    Type: Application
    Filed: October 29, 2010
    Publication date: May 5, 2011
    Inventors: Padma NANDURI, T. Aaron DYER
  • METHODS AND COSMETIC PREPARATIONS FOR THE SUSTAINED DELIVERY OF THERAPEUTIC AGENTS TO THE EYE
    Publication number: 20110104083
    Abstract: Cosmetic compositions comprising therapeutic agents for the treatment of various eye conditions and methods of use are described. In particular, the invention provides cosmetic compositions comprising ophthalmic therapeutic agents in combination with a muscle fasciculating agent for application to the outer surface of the upper eyelid, perimeter of the eyelid and/or eyelashes thereby causing transfer of the therapeutic agents into the vascular network within the eyelid for delivery into all parts of the eye, including the posterior segments of the eye, the eyelid glands, conjuctiva and periocular tissue.
    Type: Application
    Filed: October 29, 2010
    Publication date: May 5, 2011
    Inventors: Padma NANDURI, T. Aaron Dyer